PT2977 is a potential treatment for clear cell renal cell carcinoma (ccRCC). PT2977 is an orally active and selective HIF-2alpha inhibitor (IC50: 9 nM).
Molecular Weight:
383.3
Purity:
>98% (HPLC)
CAS Number:
[1672668-24-4]
Formula:
C17H12F3NO4S
* VAT and and shipping costs not included. Errors and price changes excepted